Cardiff Oncology Inc (NASDAQ:CRDF)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CRDF

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CRDF

  • Market Cap$409.770m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS14147L1089

Company Profile

Cardiff Oncology Inc is a clinical-stage company with the singular mission of developing new treatment options for cancer patients. Its objective is to overcome resistance, extend duration of response and increase overall survival.TrovaGene Inc is clinical-stage, precision medicine oncology therapeutics company. Its focus is to develop oncology therapeutics for improved cancer care and to optimize drug development by leveraging its Precision Cancer Monitoring technology.

Latest CRDF news

Currently there for this company. Visit our news hub for other news .